Skip to content

Endurance exercise at high altitude under carbohydrate supplementation

Endurance exercise at high altitude under carbohydrate supplementation - Nutrition, Sports and Altitude

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36965
Enrollment
20
Registered
2012-11-29
Start date
2012-11-29
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

op geen enkele aandoening Not applicable

Interventions

In this study with high altitude simulation cyclists perform an incremental exercise protocol 3 times (A, B, C). The only difference between the 3 protocols is the simulated altitude (sea level or 2

Sponsors

Hogeschool van Arnhem en Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male 18 years or older Semi professional cyclists Self reported healthy

Exclusion criteria

Exclusion criteria: Anaemie (Hb 5.8 mmol/L and/or glucosuria) Following a weight reduction programme or medically prescribed diet Weight change > 2 kg during the last 2 months Medication that may influence energy metabolism, weight or food intake Gastrointestinal disorders (blood in stool, constipation and/or diarrhoea) History of medical or surgical events that may affect study outcome Blood donation in the last month before the study or during the study Abnormal ECG or impaired lung function

Design outcomes

Primary

MeasureTime frame
The primary study outcome of the study for measuring energy expenditure is oxygen consumption

Secondary

MeasureTime frame
The CO2-production of the subjects is also measured. In combination with the oxygen consumption the Respiratory Quotient (RQ=CO2/O2) can be determined. Changes in RQ are indicative for changes in substrate use and could indicate a shift from fat to carbohydrate utilization.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)